Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dolby, Jean M.
and
Standfast, A. F. B.
1961.
The intracerebral infection of mice with Bordetella pertussis.
Journal of Hygiene,
Vol. 59,
Issue. 2,
p.
205.
Standfast, A. F. B.
and
Dolby, Jean M.
1961.
A comparison between the intranasal and intracerebral infection of mice with Bordetella pertussis.
Journal of Hygiene,
Vol. 59,
Issue. 2,
p.
217.
Munoz, John J.
1963.
I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF
BORDETELLA PERTUSSIS ANTIGENS
.
Bacteriological Reviews,
Vol. 27,
Issue. 4,
p.
325.
MEYNELL, G. G.
1963.
Interpretation of Distributions of Individual Response Times in microbial Infections.
Nature,
Vol. 198,
Issue. 4884,
p.
970.
WILLIAMS, TREVOR
and
MEYNELL, G. G.
1967.
Time-dependence and Count-dependence in Microbial Infection.
Nature,
Vol. 214,
Issue. 5087,
p.
473.
Dolby, Jean M.
1972.
Passive protection of mice against intracerebral infections with Bordetella pertussis.
Epidemiology and Infection,
Vol. 70,
Issue. 4,
p.
707.
Sato, Y
Izumiya, K
Sato, H
Cowell, J L
and
Manclark, C R
1980.
Aerosol infection of mice with Bordetella pertussis.
Infection and Immunity,
Vol. 29,
Issue. 1,
p.
261.
Imaizumi, Atsushi
Suzuki, Yoji
Sato, Hiroko
and
Sato, Yuji
1985.
Protective Effects of Human Gamma‐Globulin Preparations against Experimental Aerosol Infections of Mice with Bordetella pertussis.
Vox Sanguinis,
Vol. 48,
Issue. 1,
p.
18.
Iwata, M.
and
Ajiki, Y.
1986.
Effect of Human Immunoglobulin Preparations on Experimental Bordetella pertussis Infection in Mice.
Vox Sanguinis,
Vol. 51,
Issue. 3,
p.
176.
Locht, Camille
and
Keith, JerryM.
1987.
CAN PERTUSSIS BE ERADICATED BY VACCINATION?.
The Lancet,
Vol. 329,
Issue. 8535,
p.
738.
Wilkins, Jeanette
Chan, Linda S.
and
Wehrle, Paul F.
1987.
Age and dose interval as factors in agglutinin formation to pertussis vaccine.
Vaccine,
Vol. 5,
Issue. 1,
p.
49.
Roberts, M
Maskell, D
Novotny, P
and
Dougan, G
1990.
Construction and characterization in vivo of Bordetella pertussis aroA mutants.
Infection and Immunity,
Vol. 58,
Issue. 3,
p.
732.
Chen, W.
Alley, M.R.
and
Manktelow, B.W.
1991.
Clearance of ovine isolates ofBordetella parapertussisfrom murine trachea and lungs.
New Zealand Veterinary Journal,
Vol. 39,
Issue. 2,
p.
75.
Redhead, K
Watkins, J
Barnard, A
and
Mills, K H
1993.
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
Infection and Immunity,
Vol. 61,
Issue. 8,
p.
3190.
Han, Seung Beom
Kang, Kyu Ri
Huh, Dong Ho
Lee, Hee Chul
Lee, Soo Young
Kim, Jong-Hyun
Hur, Jae Kyun
and
Kang, Jin Han
2015.
Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy againstBordetella pertussisin a murine intranasal challenge model.
Clinical and Experimental Vaccine Research,
Vol. 4,
Issue. 1,
p.
75.
Huh, Dong Ho
Han, Seung Beom
Shin, Hye Jo
Ahn, Dong Ho
Choi, Gi Sub
Kang, Kyu Ri
Kim, Bo Ram
and
Kang, Jin Han
2018.
Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.
Journal of Microbiology, Immunology and Infection,
Vol. 51,
Issue. 6,
p.
732.
Weaver, Kelly L.
Bitzer, Graham J.
Wolf, M. Allison
Pyles, Gage M.
DeJong, Megan A.
Dublin, Spencer R.
Huckaby, Annalisa B.
Gutierrez, Maria de la Paz
Hall, Jesse M.
Wong, Ting Y.
Warden, Matthew
Petty, Jonathan E.
Witt, William T.
Cunningham, Casey
Sen-Kilic, Emel
Damron, F. Heath
Barbier, Mariette
and
Ho, Paulo Lee
2023.
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
PLOS ONE,
Vol. 18,
Issue. 11,
p.
e0286925.